Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have ...

A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences.

The new €3.2M (US$3.7M) research lab will investigate immunogenic cell death mechanisms in lung cancer to improve how existing therapies trigger immune response.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...

Scientists have engineered a common probiotic bacterium to act like a microscopic drug factory that hunts down tumors and delivers cancer-killing compounds directly where they’re needed. Credit: ...

Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published in the open-access journal in PLOS Biology by Tianyu ...

A foundational guide for stage 2 prostate cancer clarifies staging implications, localized-disease management, and trade-offs among surgery, radiation, and quality-of-life outcomes to support informed ...

Today, our scientists and doctors are transforming cancer care through precision immuno-oncology — tailoring immunotherapy treatments to the unique biology of each patient's cancer. At MSK, ...

The tale of this heartbroken tech entrepreneur, his tumour-riddled rescue dog and a cure for cancer has leading scientists astounded. ... Read More The post Tech boss uses AI and ChatGPT to create ...

Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...